PIK3CA mutations are associated with lower rates of pathologic complete response to anti-human epidermal growth factor receptor 2 (her2) therapy in primary HER2-overexpressing breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 8 September 2014 |
| Author/s |
author: Andreas Schneeweiss Michael Untch Sherene Loi Sibylle Loibl Carsten Denkert Peter A. Fasching Peter Sinn |
| Publication date | September 8, 2014 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |